What downturn? Pharma is back

Posted 8 May 2025 AM

The pharmaceutical industry is back to soaring revenue growth, with new analysis showing 19 of the 20 pharmas with the highest revenues saw earnings increase in 2024 compared to the previous year.

Combined, the 20 top-earning pharmas pulled in an extra $108.7 billion (US$70.16 billion) in 2024, according to data collected by Fierce Pharma, a sharp turn-around from 2023 when they saw a fall in revenue of $71 billion. Fierce considered only the revenues from the health sciences divisions of the pharmas, and converted to US dollars based on the annual average exchange rate.

To see the whole article, please login